Dr. Harry A Drabkin MD
Oncologist | Medical Oncology
171 Ashley Ave Charleston SC, 29425About
Dr. Harry Drabkin is an oncologist practicing in Charleston, SC. Dr. Drabkin specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Drabkin manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Education and Training
University of Wales in Great Britain 1977
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- DEF-3(g16/NY-LU-12), an RNA binding protein from the 3p21.3 homozygous deletion region in SCLC.
- Molecular definition of a small amplification domain within 3q26 in tumors of cervix, ovary, and lung.
- Altered HOX and WNT7A expression in human lung cancer.
- Embryonic genes in cancer.
- Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas.
- Minimal residual disease (MRD) in remission t(8;21) AML and in vivo differentiation detected by FISH and CD34+ cell sorting.
- The TRC8 hereditary kidney cancer gene suppresses growth and functions with VHL
- Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading.
- WNT7a induces E-cadherin in lung cancer cells.
- Characterization of the submicroscopic deletion in the small-cell lung carcinoma (SCLC) cell line U2020.
- The role of semaphorins in lung cancer.
- Hox expression in AML identifies a distinct subset of patients with intermediate cytogenetics.
- Growth suppression induced by the TRC8 hereditary kidney cancer gene is dependent upon JAB1/CSN5.
- Semaphorin SEMA3F has a repulsing activity on breast cancer cells and inhibits E-cadherin-mediated cell adhesion.
- Synergistic growth inhibition by Iressa and Rapamycin is modulated by VHL mutations in renal cell carcinoma.
Treatments
- Kidney Cancer
- Lung Cancer
- Acute Myeloid Leukemia (aml)
- Lymphoma
- Leukemia
- Extra Corporeal Shockwave Therapy
Dr. Harry A Drabkin MD's Practice location
Dr. Harry A Drabkin MD's reviews
Write ReviewRecommended Articles
- What Causes Pleurisy?
Pleurisy can be caused by a number of things. The causes of pleurisy are described below.InfectionsInfections are most common cause of pleurisy. The most common infection to result in pleurisy is a viral infection. However, any type of organism has the ability and potential to reach the pleural...
- Treatments for Lung Cancer
The nature of cancer, its stage, your overall health, and the condition of your lungs will largely determine the kind of treatment that safeguards your health. If you happen to be an active smoker, quitting the habit would be a precondition for quicker recovery from cancer. Lung cancer is one the...
- Talking About Breast Cancer Diagnosis
Hearing the news that you have breast cancer is an overwhelming and a life-changing moment, and breaking the news is just as hard too. Almost all patients, upon first hearing the diagnosis, become so overwhelmed that they feel some sort of "numbed" and cannot decide what to do next. It is often very...
- Can Bisphosphonates Stop Breast Cancer from Spreading to Bones?
Two years ago, at the age of 44, Susan Leonard was diagnosed with stage II breast cancer – a disease that affects over 260,000 American women on an annual basis. In order to keep her cancer from recurring, she had to undergo countless treatments, including chemotherapy, hormone therapy, a double...
- The Effect of Insurance on Breast Cancer
Early diagnosis is incredibly important in determining the chance of survival that someone with breast cancer will have. Screening and detection methods for breast cancer have made leaps and bounds over the years, but only for those people who have access to regular screening. Insurance plays a huge...
- New Treatment for Difficult To Treat Type of Ovarian Cancer
Ovarian clear cell carcinoma is one of the most difficult forms of ovarian cancers to treat, but there may be a new approach for therapy. The potential new form of therapy was discovered by Wistar scientists and discussed in detail in the online medical journal, Nature Cell Biology.Between 5 and 10...
Nearby Providers
- Dr. Whitney Graybill MD96 Jonathan Lucas Street Charleston South Carolina 29425
- Dr. Michael B Lilly M.D.171 Ashley Ave Charleston SC 29425
- Mrs. Rita K Kramer MD171 Ashley Ave Charleston SC 29425
- Dr. Elizabeth Michelle Gunderson MD171 Ashley Ave Charleston SC 29425
- Dr. Steven Alan Akman MD2085 Henry Tecklenburg Dr Charleston SC 29414
- Dr. Keisuke Shirai MD171 Ashley Ave Charleston SC 29425